, Tracking Stock Market Picks
Enter Symbol:
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

down 76.36 %

Arena Pharmaceuticals, Inc. (ARNA) rated Outperform with price target $12 by BMO Capital Markets

Posted on: Thursday,  Feb 28, 2008  10:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Outperform Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 02/28/2008. Previously BMO Capital Markets rated Buy Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
on 09/28/2007., when the stock price was $11.21. Since then, Arena Pharmaceuticals, Inc. has lost 76.36% as of 10/08/2015's recent price of $2.65.
If you would have followed the previous BMO Capital Markets's recommendation on ARNA, you would have lost 76.36% of your investment in 2932 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2008 10:25 AM Buy
7.03 12.00
as of 12/24/2008
1 Week down  -4.65 %
1 Month down  -39.55 %
3 Months down  -26.78 %
1 YTD down  -41.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2007 11:25 AM Buy
11.21 16.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy